Table 2.
All patients at the week 0 | n | r | p |
CDI vs. TCH | 58 | −0.043 | 0.374 |
CDI vs. LDL-CH | 58 | 0.024 | 0.427 |
CDI vs. HDL-CH | 58 | −0.226 | 0.043 |
CDI vs. TAG | 58 | 0.062 | 0.321 |
All patients at the week 0 | n | r | p |
TCH vs. LDL-CH | 58 | 0.882 | 0.0001 |
TCH vs. HDL-CH | 58 | 0.011 | 0.467 |
TCH vs. TAG | 58 | 0.508 | 0.0001 |
All patients at the week 0 LDL-subfractions |
n | r | p |
CDI vs. VLDL | 58 | −0.126 | 0173 |
CDI vs. IDL1 | 58 | 0.024 | 0.427 |
CDI vs. IDL2 | 58 | 0.151 | 0.129 |
CDI vs. IDL3 | 58 | 0.082 | 0.27 |
CDI vs. LDL1 | 58 | 0.046 | 0.365 |
CDI vs. LDL2 | 58 | −0.044 | 0.372 |
All patients at the week 0 HDL-subfractions |
n | r | p |
CDI vs. L-HDL1 | 58 | −0.032 | 0.405 |
CDI vs. L-HDL2 | 58 | −0.099 | 0.23 |
CDI vs. L-HDL3 | 58 | −0.446 | 0.0002 |
CDI vs. I-HDL4 | 58 | −0.169 | 0.102 |
CDI vs. I-HDL5 | 58 | 0.087 | 0.257 |
CDI vs. I-HDL6 | 58 | 0.363 | 0.003 |
CDI vs. I-HDL7 | 58 | 0.19 | 0.076 |
Om3 group at the week 6 HDL subfractions |
n | r | p |
CDI vs. L-HDL3 | 28 | 0.092 | 0.325 |
CDI vs. I-HDL6 | 28 | −0.108 | 0.296 |
CDI vs. I-HDL7 | 28 | 0.073 | 0.358 |
PON-L vs. L-HDL3 | 28 | −0.159 | 0.209 |
PON-L vs. I-HDL6 | 28 | −0.092 | 0.321 |
PON-L vs. I-HDL7 | 28 | 0.190 | 0.167 |
PON-A vs. L-HDL3 | 29 | −0.082 | 0.337 |
PON-A vs. I-HDL6 | 29 | 0.029 | 0.440 |
PON-A vs. I-HDL7 | 29 | 0.133 | 0.245 |
CDI—Children’s Depression Inventory, LDL—low density lipoprotein, HDL—high density lipoprotein, LDL-CH—low density lipoprotein cholesterol, HDL-CH—high density lipoprotein cholesterol, TCH—total cholesterol, TAG—triacylglycerol, VLDL—very low density lipoprotein, IDL—intermediate density lipoprotein, L-HDL—large HDL, I-HDL—intermediate HDL, PON-L—paraoxonase 1 with lactonase activity, PON-A—paraoxonase activity with arylesterase activity, Om3—omega-3 group, n—number of subjects, r—correlation coefficient, p—significance